---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-099306"
form_type: "8-K"
ticker: "ATXI"
cik: "0001644963"
company_name: "AVENUE THERAPEUTICS, INC."
filed_at: "2023-09-08T23:59:59+00:00"
generated_at: "2026-06-10T22:12:58.337680+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Avenue Therapeutics raises ~$550k in private placement at $0.717/share from Fortress and Rosenwald

## Summary
- Issued 767,085 shares at $0.717/share (Nasdaq closing bid on Sept 7, 2023) to Fortress Biotech and Dr. Lindsay Rosenwald.
- No underwriting or placement agent fees incurred; gross proceeds ~$550,000.
- Proceeds intended for working capital and general corporate purposes.
- Registration rights agreement obligates filing of resale registration statement by September 8, 2024.

## SEC filing metadata
- accession: 0001104659-23-099306
- form_type: 8-K
- ticker: ATXI
- cik: 0001644963
- company_name: AVENUE THERAPEUTICS, INC.
- filed_at: 2023-09-08T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1644963/000110465923099306/0001104659-23-099306-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1644963/000110465923099306/tm2325730d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-099306
- JSON: https://secwatch.observer/filing/0001104659-23-099306.json
- Plain text: https://secwatch.observer/filing/0001104659-23-099306.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.